nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—bile duct cancer	0.00164	0.00164	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—PTGS2—bile duct cancer	0.00161	0.00161	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—TGFB1—bile duct cancer	0.00161	0.00161	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—GNAS—bile duct cancer	0.00159	0.00159	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—NRAS—bile duct cancer	0.00153	0.00153	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—bile duct cancer	0.00153	0.00153	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—bile duct cancer	0.00153	0.00153	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFBR2—bile duct cancer	0.00149	0.00149	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HGF—bile duct cancer	0.00149	0.00149	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—ERBB2—bile duct cancer	0.00147	0.00147	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—bile duct cancer	0.00146	0.00146	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—KRAS—bile duct cancer	0.00145	0.00145	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—GNAS—bile duct cancer	0.00144	0.00144	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MMP9—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SMAD4—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL6—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—bile duct cancer	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—KRAS—bile duct cancer	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HGF—bile duct cancer	0.00126	0.00126	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HRAS—bile duct cancer	0.00124	0.00124	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IL6—bile duct cancer	0.00118	0.00118	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TGFB1—bile duct cancer	0.00117	0.00117	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—TGFB1—bile duct cancer	0.00114	0.00114	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—HRAS—bile duct cancer	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—NRAS—bile duct cancer	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—FAR2—bile duct cancer	0.00112	0.00112	CbGpPWpGaD
Pseudoephedrine—TNF—Selenium Micronutrient Network—IL6—bile duct cancer	0.00111	0.00111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—GNAS—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—TGFB1—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—IL6—bile duct cancer	0.00107	0.00107	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NOS2—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—NRAS—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFBR2—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00104	0.00104	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—bile duct cancer	0.00102	0.00102	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—GNAS—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—bile duct cancer	0.00101	0.00101	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SMAD4—bile duct cancer	0.00099	0.00099	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000987	0.000987	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—TGFB1—bile duct cancer	0.000978	0.000978	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TGFB1—bile duct cancer	0.000977	0.000977	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—KRAS—bile duct cancer	0.000963	0.000963	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—bile duct cancer	0.000959	0.000959	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000945	0.000945	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—SMAD4—bile duct cancer	0.000937	0.000937	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00092	0.00092	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—KRAS—bile duct cancer	0.000905	0.000905	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFBR2—bile duct cancer	0.000884	0.000884	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—GNAS—bile duct cancer	0.000883	0.000883	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.000878	0.000878	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL6—bile duct cancer	0.000878	0.000878	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—TGFB1—bile duct cancer	0.000867	0.000867	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—GNAS—bile duct cancer	0.000864	0.000864	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—bile duct cancer	0.000861	0.000861	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB2—bile duct cancer	0.000857	0.000857	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GNAS—bile duct cancer	0.000853	0.000853	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SMAD4—bile duct cancer	0.000837	0.000837	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—bile duct cancer	0.000819	0.000819	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—IDH2—bile duct cancer	0.000817	0.000817	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—KRAS—bile duct cancer	0.000814	0.000814	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000813	0.000813	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—bile duct cancer	0.000813	0.000813	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000807	0.000807	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—bile duct cancer	0.000804	0.000804	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000793	0.000793	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB2—bile duct cancer	0.000791	0.000791	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—bile duct cancer	0.000784	0.000784	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000777	0.000777	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—bile duct cancer	0.000774	0.000774	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—bile duct cancer	0.000771	0.000771	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	0.00077	0.00077	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—bile duct cancer	0.000769	0.000769	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000734	0.000734	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FAR2—bile duct cancer	0.000729	0.000729	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—bile duct cancer	0.000725	0.000725	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB2—bile duct cancer	0.000725	0.000725	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—bile duct cancer	0.000723	0.000723	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MET—bile duct cancer	0.000717	0.000717	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000715	0.000715	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—GNAS—bile duct cancer	0.000715	0.000715	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—IDH1—bile duct cancer	0.000703	0.000703	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000702	0.000702	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.000666	0.000666	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—GNAS—bile duct cancer	0.000664	0.000664	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—bile duct cancer	0.000664	0.000664	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000653	0.000653	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—bile duct cancer	0.000652	0.000652	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RNF43—bile duct cancer	0.000607	0.000607	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—bile duct cancer	0.000603	0.000603	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—bile duct cancer	0.000602	0.000602	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP2—bile duct cancer	0.000598	0.000598	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RNF43—bile duct cancer	0.000594	0.000594	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—bile duct cancer	0.000594	0.000594	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GNAS—bile duct cancer	0.000594	0.000594	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000571	0.000571	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HGF—bile duct cancer	0.000566	0.000566	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KRAS—bile duct cancer	0.000561	0.000561	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—bile duct cancer	0.000559	0.000559	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB2—bile duct cancer	0.000554	0.000554	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—bile duct cancer	0.000551	0.000551	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—bile duct cancer	0.00055	0.00055	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—bile duct cancer	0.000548	0.000548	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—IDH2—bile duct cancer	0.000546	0.000546	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00053	0.00053	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—bile duct cancer	0.000529	0.000529	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ERBB2—bile duct cancer	0.000524	0.000524	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—KRAS—bile duct cancer	0.000519	0.000519	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KRAS—bile duct cancer	0.000518	0.000518	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—bile duct cancer	0.000502	0.000502	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GNAS—bile duct cancer	0.000499	0.000499	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RNF43—bile duct cancer	0.000491	0.000491	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GNAS—bile duct cancer	0.000488	0.000488	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bile duct cancer	0.000482	0.000482	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—bile duct cancer	0.000477	0.000477	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—bile duct cancer	0.000475	0.000475	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KRAS—bile duct cancer	0.000475	0.000475	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—IDH1—bile duct cancer	0.00047	0.00047	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB2—bile duct cancer	0.000469	0.000469	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC5A5—bile duct cancer	0.000464	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RNF43—bile duct cancer	0.000457	0.000457	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GNAS—bile duct cancer	0.000453	0.000453	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—bile duct cancer	0.00045	0.00045	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000447	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GNAS—bile duct cancer	0.000443	0.000443	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—bile duct cancer	0.000441	0.000441	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—bile duct cancer	0.00044	0.00044	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—bile duct cancer	0.000437	0.000437	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS2—bile duct cancer	0.000434	0.000434	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—bile duct cancer	0.000423	0.000423	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—bile duct cancer	0.000421	0.000421	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—bile duct cancer	0.000421	0.000421	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—bile duct cancer	0.000406	0.000406	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GNAS—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—bile duct cancer	0.000403	0.000403	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—bile duct cancer	0.000402	0.000402	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—bile duct cancer	0.000399	0.000399	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—bile duct cancer	0.000392	0.000392	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000387	0.000387	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—bile duct cancer	0.000386	0.000386	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—bile duct cancer	0.000384	0.000384	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GNAS—bile duct cancer	0.000375	0.000375	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000371	0.000371	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—bile duct cancer	0.000371	0.000371	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GNAS—bile duct cancer	0.000367	0.000367	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—bile duct cancer	0.000363	0.000363	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KRAS—bile duct cancer	0.000363	0.000363	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNAS—bile duct cancer	0.00036	0.00036	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IDH2—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KRAS—bile duct cancer	0.000343	0.000343	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GNAS—bile duct cancer	0.000341	0.000341	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—bile duct cancer	0.000331	0.000331	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—bile duct cancer	0.000325	0.000325	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—bile duct cancer	0.000322	0.000322	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC5A5—bile duct cancer	0.00031	0.00031	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—bile duct cancer	0.000308	0.000308	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KRAS—bile duct cancer	0.000307	0.000307	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IDH1—bile duct cancer	0.000306	0.000306	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—bile duct cancer	0.000295	0.000295	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—bile duct cancer	0.000292	0.000292	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—bile duct cancer	0.000279	0.000279	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFBR2—bile duct cancer	0.000278	0.000278	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—bile duct cancer	0.000273	0.000273	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFBR2—bile duct cancer	0.000271	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GNAS—bile duct cancer	0.000268	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMAD4—bile duct cancer	0.000263	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GNAS—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—bile duct cancer	0.000261	0.000261	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMAD4—bile duct cancer	0.000257	0.000257	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—bile duct cancer	0.00025	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—bile duct cancer	0.000248	0.000248	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GNAS—bile duct cancer	0.000241	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—bile duct cancer	0.00023	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFBR2—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNAS—bile duct cancer	0.000217	0.000217	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—bile duct cancer	0.000213	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMAD4—bile duct cancer	0.000213	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFBR2—bile duct cancer	0.000209	0.000209	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC5A5—bile duct cancer	0.000202	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNAS—bile duct cancer	0.000201	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMAD4—bile duct cancer	0.000197	0.000197	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—bile duct cancer	0.00019	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—bile duct cancer	0.000189	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—bile duct cancer	0.000173	0.000173	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—bile duct cancer	0.000169	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—bile duct cancer	0.000159	0.000159	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNAS—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—bile duct cancer	0.000153	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—bile duct cancer	0.000147	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—bile duct cancer	0.000142	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—bile duct cancer	0.00014	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—bile duct cancer	0.000132	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—bile duct cancer	0.000123	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—bile duct cancer	0.000123	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—bile duct cancer	0.000119	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—bile duct cancer	0.000112	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—bile duct cancer	0.000112	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—bile duct cancer	0.000111	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—bile duct cancer	0.000104	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—bile duct cancer	0.000104	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—bile duct cancer	9.97e-05	9.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—bile duct cancer	9.97e-05	9.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—bile duct cancer	9.63e-05	9.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—bile duct cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—bile duct cancer	9.42e-05	9.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—bile duct cancer	9.05e-05	9.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—bile duct cancer	8.56e-05	8.56e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—bile duct cancer	8.42e-05	8.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—bile duct cancer	8.41e-05	8.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—bile duct cancer	8.41e-05	8.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—bile duct cancer	8.37e-05	8.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—bile duct cancer	8.25e-05	8.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—bile duct cancer	8.18e-05	8.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—bile duct cancer	8.01e-05	8.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—bile duct cancer	7.83e-05	7.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—bile duct cancer	7.81e-05	7.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—bile duct cancer	7.79e-05	7.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—bile duct cancer	7.66e-05	7.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—bile duct cancer	7.66e-05	7.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—bile duct cancer	7.24e-05	7.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—bile duct cancer	6.92e-05	6.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—bile duct cancer	6.62e-05	6.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—bile duct cancer	6.43e-05	6.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—bile duct cancer	6.34e-05	6.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—bile duct cancer	6.15e-05	6.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—bile duct cancer	5.89e-05	5.89e-05	CbGpPWpGaD
